HR HealthCare Acquires SteriGear And Fig Leaf Brand To Expand Urology Solutions

By Amit Chowdhry • Jun 18, 2026

HR HealthCare announced that it has acquired SteriGear, including the Fig Leaf brand of urinary drainage devices and SteriGear’s portfolio of covers and drapes.

The acquisition strengthens HR HealthCare’s ability to provide bladder management solutions across the care continuum, including acute care, post-acute care, long-term care, skilled nursing, and home-based care.

SteriGear is known for the Fig Leaf urinary drainage bag, which is designed to preserve patient dignity by concealing fluid from view through a built-in privacy cover. The company also offers covers and drapes that help protect equipment and support procedural efficiency.

HR HealthCare said SteriGear’s products have already gained adoption in skilled nursing and long-term care settings. Through the acquisition, the company plans to expand the reach of the products and adapt configurations for acute care, health systems, and home-based care.

The deal also brings SteriGear and Fig Leaf together with HR HealthCare’s TruCath products and broader urology platform. The combined portfolio is expected to give channel partners and health systems access to a more complete set of urology and drainage solutions through a single coordinated source.

Under the transition plan, the Fig Leaf brand will remain in the market. The SteriGear brand will transition to HR HealthCare over time through phased updates to marketing, packaging, and labeling.

HR HealthCare said there will be no changes to item numbers, product quality, specifications, or performance. Customers should expect the same clinical effectiveness and reliability from the acquired products.

The SteriGear website is expected to transition to HR HealthCare no later than August 1, 2026. Additional details regarding customer transition and ordering will be communicated directly to customers and partners as part of the integration process.

Support: Miles & Stockbridge served as legal counsel to HR HealthCare. Capital Eleven served as exclusive financial advisor to SteriGear, and Dorsey & Whitney served as legal counsel to SteriGear.

KEY QUOTES:

“This acquisition is about more than adding products to our portfolio. It means we can do more—protect patient dignity with products like Fig Leaf, leverage our expanded product line to bring care-setting-specific solutions to more clinicians, patients, and caregivers, and deliver on our purpose of positively impacting people’s lives.”

Colby Wiesman, President and CEO of HR HealthCare

“Our customers are asking for clinically sound urology solutions that are easier to access and implement. Consolidating this expanded portfolio within a single organization means we can serve as a true partner, streamlining how care teams source and implement these offerings alongside our broader urological portfolio, supporting education and training, and ultimately helping more patients receive consistent, dignified care.”

Chris Wiesman, Chief Commercial Officer of HR HealthCare